Tenaya Therapeutics has been granted a patent for compounds that inhibit HDAC6 activity, potentially treating various diseases. The formula for the compound is provided in the claim. GlobalData’s report on Tenaya Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Tenaya Therapeutics, Recombinant AAV gene therapy was a key innovation area identified from patents. Tenaya Therapeutics's grant share as of February 2024 was 8%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11926622B2) discloses a series of compounds with specific chemical formulas and structures. The compounds described in the patent exhibit various configurations and substitutions, including different alkyl, cycloalkyl, and heteroaryl groups. For instance, the compounds may contain phenyl groups that are optionally substituted with halogen, alkyl, alkoxy, or heteroaryl moieties. Additionally, the patent covers compounds where certain groups combine to form heterocyclyl or cyclopropyl structures, further expanding the chemical diversity of the disclosed compounds.
Furthermore, the patent includes compounds with specific arrangements of atoms and functional groups, such as O or CH2 linkers and methyl (CH3) substituents. The compounds may also feature cyclopropyl groups substituted with fluorine or methyl groups. The patent encompasses a range of structural variations within the defined chemical formulas, allowing for flexibility in designing and synthesizing novel compounds with potential applications in various fields. Overall, the granted patent provides a detailed framework for the synthesis and utilization of these compounds, offering valuable insights for researchers and professionals in the pharmaceutical and chemical industries.
To know more about GlobalData’s detailed insights on Tenaya Therapeutics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
